Országos Onkológiai Intézet / National Institute of Oncology

Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database (2021) Hannoun-Levi JM, Gal J, Van Limbergen E, Chand ME, Schiappa R, Smanyko V, Kauer-Domer D, et al. Journal article Radiotherapy-induced changes in the systemic immune and inflammation parameters of head and neck cancer patients (2019) Balazs K, Kis E, Badie C, Bogdandi EN, Candeias S, Garcia LC, Dominczyk I, et al. Journal article 2nd conservative Treatment for 2nd ipsilateral Breast Tumor Event: Mature Oncological Results and Prognostic Factors from the GEC-Estro Bcwg. (2019) Levi JMH, Kauer-Dorner D, Guix B, Gal J, Schiappa R, Polgar C, Gutierrez C, et al. Conference contribution A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk (2018) Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, et al. Journal article QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Conference contribution ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations (2018) Strnad V, Major T, Polgar C, Lotter M, Guinot JL, Gutierrez-Miguelez C, Galalae R, et al. Journal article Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis (2018) Levi JMH, Van Limbergen E, Gal J, Schiappa R, Polgar C, Kauer-Dorner D, Pasquier D, et al. Conference contribution Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Journal article Risk factors and state-of-the-art indications for boost irradiation in invasive breast carcinoma (2017) Polo A, Polgar C, Hannoun-Levi JM, Guinot JL, Gutierrez C, Galalae R, Van Limbergen E, Strnad V Journal article Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial (2017) Polgar C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, et al. Journal article